The importance of histology in patient selection for platinum-based neoadjuvant treatment in non-small cell lung cancer
Tumor histology may serve as a prognostic factor, helping to predict patient outcomes and guide the selection of neoadjuvant therapies before surgery. Currently, platinum-based chemotherapies are still used as a standard. Clinicians should consider tumor histology while deciding on neoadjuvant treatment.
Authors
- Bülent Mustafa Yenigün (ORCID: https://orcid.org/0000-0001-6543-5441)
- Gökhan Kocaman (ORCID: https://orcid.org/0000-0001-5572-264X)
- Elif Berna Köksoy (ORCID: https://orcid.org/0000-0002-6590-4444)
- Rıfat Murat Akal (ORCID: https://orcid.org/0000-0002-5062-5901)
- Hakan Kutlay (ORCID: https://orcid.org/0000-0003-1074-3409)
- Yusuf Kahya (ORCID: https://orcid.org/0000-0002-0766-7946)
- Atilla Halil Elhan (ORCID: https://orcid.org/0000-0003-3324-248X)
- Cabir Yüksel (ORCID: https://orcid.org/0000-0002-3480-4803)
- Serkan Enön (ORCID: https://orcid.org/0000-0001-9529-714X)
- Ayten Cangır (ORCID: https://orcid.org/0000-0002-2052-1642)
- Murat Özkan (ORCID: https://orcid.org/0000-0002-8265-2680)
Institutions
- Ankara University (TR)
Publication Details
- Journal
- Turkish Journal of Thoracic and Cardiovascular Surgery
- Published
- 2025-03-05
- DOI
- https://doi.org/10.5606/tgkdc.dergisi.2025.27340
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00